SCHEMBL6580697

SCHEMBL6580697

CCOC(=O)c1cn(-c2cc(NC=O)c(F)cc2C)c2c(C)c(F)c(F)cc2c1=O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
STAT3 P40763 3/20 0.52
KMT2A Q03164 2/20 0.42
PIM1 P11309 1/20 0.41
IRAK1 P51617 1/20 0.41
CAMK2B Q13554 1/20 0.41
CAMK2G Q13555 1/20 0.41
CAMK2D Q13557 1/20 0.41
PIM3 Q86V86 1/20 0.41
HTT P42858 1/20 0.41
ADRB2 P07550 1/20 0.40
ROCK2 O75116 1/20 0.39
CDK1 P06493 1/20 0.39
PRKACA P17612 1/20 0.39
CDK2 P24941 1/20 0.39
CSNK1D P48730 1/20 0.39
GSK3A P49840 1/20 0.39
CDK5 Q00535 1/20 0.39
PRKCD Q05655 1/20 0.39
ROCK1 Q13464 1/20 0.39
CDC42BPA Q5VT25 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6578865 0.91 STAT3 (0.50) STAT3KMT2APIM1IRAK1CAMK2B
SCHEMBL7003690 0.86 STAT3 (0.51) STAT3KMT2APIM1IRAK1CAMK2B
SCHEMBL6578888 0.83 STAT3 (0.54) STAT3KMT2APIM1IRAK1CAMK2B
SCHEMBL7007984 0.82 STAT3 (0.50) STAT3KMT2AHTTADRB2KDM4E
SCHEMBL6580577 0.81 STAT3 (0.52) STAT3KMT2APIM1IRAK1CAMK2B
SCHEMBL7008549 0.79 STAT3 (0.61) STAT3KMT2APIM1IRAK1CAMK2B
SCHEMBL6576291 0.78 STAT3 (0.47) STAT3KMT2APIM1IRAK1CAMK2B
SCHEMBL6578628 0.77 STAT3 (0.52) STAT3KMT2APIM1IRAK1CAMK2B
SCHEMBL7007194 0.77 STAT3 (0.54) STAT3KMT2APIM1IRAK1CAMK2B
SCHEMBL20912620 0.77 STAT3 (0.52) STAT3KMT2APIM1IRAK1CAMK2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0897919-B1 NOVEL PYRIDONECARBOXYLIC ACID DERIVATIVES OR SALTS THEREOF AND ANTIBACTERIAL AGENTS CONTAINING THE SAME AS THE ACTIVE INGREDIENT WAKUNAGA PHARMA CO LTD (JP) 2004-06-16 EP disclosed
US-6211375-B1 IMPROVED INTESTINAL ABSORPTION WAKUNAGA PHARMACEUTICAL CO., LTD. (JP) 2001-04-03 US disclosed
EP-0897919-A1 NOVEL PYRIDONECARBOXYLIC ACID DERIVATIVES OR SALTS THEREOF AND ANTIBACTERIAL AGENTS CONTAINING THE SAME AS THE ACTIVE INGREDIENT WAKUNAGA PHARMACEUTICAL CO., LTD. (JP) 1999-02-24 EP disclosed